Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige

Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.

Jamie Dimon Says He Is 'Cautious About Everything' Amid Recession Fears: 'Always A Mistake To Look At Just The Year'

Benzinga Neuro
February 26, 2024

JPMorgan CEO Jamie Dimon has expressed his concerns about the U.S. economy, warning of a potential recession and the market’s underestimation of the risks.

What Happened: Dimon, speaking at the JPMorgan High Yield and Leveraged Finance Conference in Miami on Monday, cautioned that the U.S. might be on the brink of a recession. Despite this, he does not foresee any systemic issues, reported CNBC.

Dimon pointed out that there are concerns about certain factors and expressed disagreement with the high probability assigned to the economy avoiding a recession.

Dimon highlighted several factors that could impact the economy, including the market’s current pricing of a “soft landing,” the Federal Reserve’s quantitative tightening, and the U.S.’s fiscal spending deficits. He believes that these factors might play out over several years, potentially causing a significant impact.

"The market is kind of pricing in a soft landing. That may very well happen. But the [market's] odds are 70 to 80%. I'll give you half that, that's all," said Dimon, according to the report.

See Also: ‘Dogecoin Killer’ Shiba Inu Witnesses Massive 421.6B Token Move By Whale, Resulting In $6M+ Loss

Dimon’s comments come at a time when the market is reassessing its expectations for monetary policy. Futures traders, who previously predicted an aggressive series of interest rate cuts starting in March, now see the easing not commencing until June or July, with three cuts priced in — half of the previous expectations.

"It's always a mistake to look at just the year," Dimon said. "All these factors we talked about: QT, fiscal spending deficits, the geopolitics, those things may play out over multiple years. But they will play out and they will have an effect and in my mind I'm just kind of cautious about everything.

Dimon does not anticipate a recurrence of previous significant downturns in the U.S. economy, like the 2008 financial crisis, which witnessed Wall Street’s plunge due to fallout from the subprime mortgage industry collapse, according to the report.

"If we have a recession, yes, it'll get worse. If we don't have a recession, I think most people will be able to muddle through this," Dimon said explaining that this is partly a normalization process. Rates were exceptionally low for an extended period. If rates increase and a recession occurs, real estate problems will emerge, with some banks likely experiencing more significant challenges in this area than others.

Why It Matters: Dimon’s warning about a potential recession is a significant development. This comes in the wake of his earlier caution about the escalating U.S. national debt, where he raised concerns about a potential global market “rebellion.”

Dimon has also been vocal about the challenges faced by traditional banks, including JPMorgan, in the face of fintech competition and regulatory burdens. His latest warning about a possible recession further underscores the complexities and uncertainties facing the U.S. economy.

Despite these concerns, Dimon has also expressed optimism about the potential of AI to improve almost every aspect of our lives, indicating that amid the challenges, there may also be opportunities for innovation and growth.

Read Next: Max Keiser Says Buying Bitcoin Now Is Like Getting Berkshire Hathaway Shares At $1500 — Here’s What It Means For Apex Crypto

Image Via Flickr


Engineered by Benzinga Neuro, Edited by Kaustubh Bagalkote


The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Continue Reading...

Popular

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Microsoft enters approximately $9.7B contract with IREN that gives it access to Nvidia chips

Microsoft has entered into a $9.7 billion cloud services contract with artificial intelligence cloud service provider IREN that will give it access to some of Nvidia's chips.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

France threatens to block Shein over sale of childlike sex dolls ahead of Paris store opening

PARIS (AP) — French authorities have warned they may block access to after it emerged that the online fast fashion giant had been selling sex dolls with a childlike appearance.

Elon Musk Tells Joe Rogan: 'Trump Actually Is Not Perfect, but He's Not Evil'

In a Friday appearance on The Joe Rogan Podcast, Elon Musk defended President Donald Trump, stating that while Trump is "not perfect," he is also "not evil."

Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad

You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1

China EV Heat Check: Nio, Li Auto, XPeng on Fire

Nio, Li Auto and XPeng set October delivery records, powered by overseas expansion and advancing EV tech.

Abu Dhabi hosts oil summit as OPEC+ halts production hikes planned for first quarter of 2026

ABU DHABI, United Arab Emirates (AP) — Abu Dhabi hosted a major oil summit Monday, hours after the OPEC+ cartel and its allies said it would halt further production increases planned in the first quarter of 2026 over concerns of too much supply in the market.

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Trump Defends Missile Strike On 'Drug-Carrying' Submarine Amid Human Rights Outcry

Trump defends strike on drug sub, says it targeted fentanyl-laden vessel heading to US. Two survivors were rescued.

Cathie Wood Dumps $3.7 Million Of Palantir Stock Despite AI Boom — Here's What She's Buying Instead

Ark Invest boosted positions in Qualcomm and BYD, while trimming Palantir and Shopify. Ark also acquired shares of China's BYD despite recent recall.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as January 29.

Jim Cramer Warns 'Don't Be Fooled' Because Speculators In Gold, Quantum And Nuclear Energy Aren't Going Down 'Without A Fight'

Former hedge fund manager and renowned CNBC TV host Jim Cramer is sounding the alarm on certain speculative pockets of the market, urging investors to sell into the "snapback" momentum if they haven't already done so.

The $43B Big Pharma Story is Starting Over-With a New Player - Ad

Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.

Trump Hosts 'Great Gatsby' Halloween Bash on Eve of SNAP Crisis

In the midst of a crisis concerning SNAP funding, President Trump held a "Great Gatsby"-themed Halloween celebration at his Mar-a-Lago resort.

The Wall Street Elites Are Moving Their Money Here - Ad

Something far more consequential for your money than tariffs is unfolding behind the scenes... Tucked inside this overlooked directive is a plan set to be executed for the first time in in U.S. history. One Stansberry Research's Senior Partner says it's set to trigger a rare window for potentially explosive gains in ONE asset immediately. (Not AI or crypto). Wall Street insiders are already positioning themselves... and he insists you should, too, before it's too late.

Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs

Orforglipron meets key endpoints in Phase 3 trials, showing A1C reduction, weight loss, and cardiovascular benefits for type 2 diabetes.

Trump Warns Supreme Court Tariff Ruling Could 'Literally Destroy' The US: 'We'll Be Struggling For Years'

President Donald Trump warned that the U.S. economy would face significant challenges if the Supreme Court rules against the majority of the tariffs imposed this year.

Elon's Haters Are About to Lose Their Minds... - Ad

Elon's empire looks doomed - crashing sales, lost tax credits, and media backlash. But behind the scenes, Tesla is about to unleash a breakthrough Forbes calls a "multi-trillion-dollar opportunity." It's not the end - it's the start of a 25,000% AI comeback.

OpenAI's ChatGPT To Allow Erotica For Adults: Not 'Moral Police Of The World,' Sam Altman Says

OpenAI will begin allowing erotica and adult-themed content on ChatGPT, marking a major shift in the company's content policy.

Journalists turn in access badges, exit Pentagon rather than agree to new reporting rules

WASHINGTON (AP) — Dozens of reporters turned in access badges and exited the Pentagon on Wednesday rather than agree to government-imposed , pushing journalists who cover the American military further from the seat of its power. The U.S. government has called the new rules “common sense.”

From Ore to Gold Bars-This Nevada Mine Is Already Producing - Ad

Most juniors explore...Few actually produce. This one's already pouring gold thanks to infrastructure that would cost tens of millions to build today. With major land holdings and room to scale, it's one to watch.

2,000 mink released from Iowa farm in what trade group calls 'terrorist act'

One or more intruders broke into an Iowa mink farm and released 2,000 of the furbearing animals in what a trade group called a “terrorist act” under federal law.

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

L3Harris Lands $2.26 Billion South Korea Air Defense Contract

L3Harris won a $2.26B deal to deliver modified Bombardier Global 6500 AEW&C aircraft to the South Korean Air Force.

Central Banks Are Buying More Gold Than Ever-And This U.S. Miner Is Ready to Oblige - Ad

Central banks are rapidly increasing their gold reserves-now nearly 20% of global assets. With rising demand and geopolitical pressure, U.S. gold supply is becoming more strategic than ever.

Nearly 8 Million Shiba Inu Vanish After First SHIB ETF Filing Shakes Market

Nearly 8 million Shiba Inu (CRYPTO: SHIB) tokens have been incinerated following the inaugural filing of a Shiba Inu ETF, rekindling interest in the popular meme token.

A Tiny Biotech Just Posted 10× Stronger Cancer Results - Ad

Early studies show this breakthrough delivery platform would make cancer treatments safer and more powerful. Now, with Big Pharma watching closely, investors are starting to take notice of what could be the next major biotech story.

Trump Administration Explores Possible Meeting With Kim Jong Un During Asia Trip

Trump considers meeting Kim Jong Un during upcoming Asia trip, but no concrete plans have been made amid ongoing China trade negotiations.

Gold Bars Are Pouring, but This Miner is Still Priced Like a Startup - Ad

You'd expect a gold miner with production, a full refinery, and big-name investors to be trading at a premium. But this one? It's still under $1

Is Big Pharma's Next Target Already in Play? - Ad

A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.

Here's Why You Need To Watch Bitcoin If You're Betting On ETH, XRP

Crypto analyst Benjamin Cowen says that a true altcoin season will only begin once both Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) reach new all-time highs, marking a structural shift

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service